Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-067-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity (similar to OECD TG 401): LD50 = 1060 mg/kg bw (for females being the lower value. For males the LD50 males = 2000 mg/kg bw)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 20, 1980 - April 5, 1980
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- Study performed prior to introduction of guideline
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: TacN(SD)fBR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Taconic Farms (Germantown, N.Y.)
- Females (if applicable) nulliparous and non-pregnant: no information
- Age at study initiation: young adult
- Weight at study initiation: 180-280 grams
- Fasting period before study: overnight
- Housing: individually in wire cages under standard laboratory conditions
- Diet (e.g. ad libitum): ad libitum, Purina Rodent Laboratory Chow 5001
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 7 days
- Route of administration:
- oral: gavage
- Vehicle:
- ethanol
- Remarks:
- SDA 39C
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: Appropriate for each dose level
MAXIMUM DOSE VOLUME APPLIED: 5.0 ml/kg bw
STARTING DOSE:
- Rationale for the selection of the starting dose: a preliminary dose range finding study was done to determine mortality. Two fasted rats (one male one female) were used per dose, administered the test substance and observed for the next 72 hours to determine mortality. At the initial dose of 5.0 g/kg bw, both male and female rat died. Subsequently doses of 0.1, 0.5 and 1.0 g/kg bw were used and all rats survived. - Doses:
- 1.0, 1.4, 1.8, 2.4, and 3.2 g/kg bw in males and females.
Additional groups of females only 0.63, 0.79, 1.0, 1.26 and 1.59 g/kg bw. - No. of animals per sex per dose:
- 8
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: the animals were observed at 1, 3, 5 and 24 hours after application and thereafter twice daily (once daily on weekends).
- Necropsy of survivors performed: yes, at the end of the observation period the animals were killed by ether inhalation, necropsied and subjected to examination for gross pathological changes.
- Body weights: Individual body weights were recorded before fasting, immediately before treatment and then on the 14th day of the observation period. - Statistics:
- According to J.T. Litchfield, Jr. and F. Wilcoxon, 1949, 'A Simplified Method of Evaluating Dose-Effect Experiments', J. Pharm. Exp. Therap., 96:99-115.
- Preliminary study:
- Range finding study in 2 rats: the initial dose was 5.0 grams per kilogram body weight and both rats died. Subsequenty doses of 0.1, 0.5 and 1.0 g/kg were used and all rats survived.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 060 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 853 - <= 1 318
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 535 - <= 2 606
- Mortality:
- Mortality rate in males per dose: 1/8 (1.0 g/kg), 3/8 (1.4 g/kg), 4/8 (1.8 g/kg), 2/8 (2.4 g/kg) and 7/8 (3.2 g/kg).
Mortality rate in females per dose (first group): 4/8 (1.0 g/kg), 8/8 (1.4 g/kg), 7/8 (1.8 g/kg), 7/8 (2.4 g/kg) and 8/8 (3.2 g/kg).
Mortality rate in females per dose (second group): 1/8 (0.63 g/kg), 5/8 (0.79 g/kg), 7/8 (1.0 g/kg), 8/8 (1.26 g/kg) and 5/8 (1.59 g/kg). - Clinical signs:
- At the lowest dose 1.0 g/kg in males and 0.63 g/kg in females, animals were prone or ataxic for the remainder of the day after dosing. Survivors recovered in the next day and appeared normal from day two and three, respectively, for the remainder of the study. At higher doses, similar signs occured and soft stools were relatively frequent. Less frequent signs were chromodacryorrhea, clonic convulsions and wetness of the fur around the mouth.
In general, clinical signs observed included ataxia, lacrimation, prone position, tremors, lethargy, chromodacryorrhea, twitches/jerks, unkempt fur, chromorinhorrhea, piloerection, abdominal gripping, diarrhea, moribund, hyperresponsiveness to external stimuli, hematuria and oral discharge. - Body weight:
- All surviving animals gained weight in a normal pattern.
- Gross pathology:
- No signs of systemic toxicity were found in any animal necropsied at termination. Common signs in animals that died were yellow fluid in the stomach (probably test article) and reddish fluid in the intestines. In two animals red lining of the intestines is observed from which one animal also showed red lining of the stomach. Furthermore in one animal black fluid in the intestines was observed and in one animal autolysis of tissue in other than standard examined tissues.
- Interpretation of results:
- other: Acute Oral Toxicity, Category 4
- Remarks:
- in accordance with EU CLP (EC 1272/2008 and its updates)
- Conclusions:
- The calculated acute oral LD50 for males was 2000 (95% Cl 1535-2606) mg/kg bw, and the calculated acute oral LD50 for females was 1060 (95% Cl 853-1318) mg/kg bw. Based on the results of this study it is concluded that Dimeth Cyclormol should be classified as harmful if swallowed.
- Executive summary:
An acute oral toxicity study was performed according to a method similar to OECD TG 401, not under GLP and therefore receives Kl. 2. In this study, 80 rats (40 males and 40 females) were administered Dimeth Cyclormol at dose levels of 1.0, 1.4, 1.8, 2.4, and 3.2 g/kg bw resulting in mortality rates of 1/8, 3/8, 4/8, 2/8, and 7/8 for males and 4/8, 8/8, 7/8, 7/8 and 8/8, respectively.The calculated acute oral LD50 for males was 2000 (95% Cl 1535-2606) mg/kg bw, and the calculated acute oral LD50 for females was 1060 (95% Cl 853-1318) mg/kg bw.
Clinical signs: At the lowest dose 1.0 g/kg in males and 0.63 g/kg in females, animals were prone or ataxic for the remainder of the day after dosing. Survivors recovered in the next day and appeared normal from day two and three, respectively, for the remainder of the study. At higher doses similar signs occurred and soft stools were relatively frequent. Other signs that occurred sporadically were e.g. chromodacryorrhea, clonic convulsions, and wetness of the fur around the mouth. All surviving animals gained weight in a normal pattern.
Necropsy: No signs of systemic toxicity were found in animals necropsied at termination. Common signs in animals that died were yellow fluid in the stomach (probably test article) and reddish fluid in the intestines. In two animals red lining of the intestines is observed from which one animal also showed red lining of the stomach. Furthermore in one animal black fluid in the intestines was observed and in one animal autolysis of tissue in other than standard examined tissues.
Supporting 2nd study (which is part of the report in which the key study is presented) An additional groups of 8 females were dosed 0.63, 0.79, 1.0, 1.26 and 1.59 g/kg bw and a mortality rate of 1/8, 5/8, 7/8, 8/8 and 5/8 animals was found, respectively.The LD50 in the additional females was not calculated in absence of a clear dose response. A new study in females was performed.
Reference
Dosage (g/kg) |
Mortality males |
Mortality females (first group) |
Mortality females (second group) |
All surviving animals were normal by day |
0.63 |
|
|
1/8 |
3 |
0.79 |
|
|
5/8 |
5 |
1.0 |
1/8 |
4/8 |
7/8 |
All but one on day 2, one on day 5 |
1.26 |
|
|
8/8 |
|
1.4 |
3/8 |
8/8 |
|
2 |
1.59 |
|
|
5/8 |
4 |
1.8 |
4/8 |
7/8 |
|
3 |
2.4 |
2/8 |
7/8 |
|
All but one on day 2, one on day 3 |
3.2 |
7/8 |
8/8 |
|
2 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 060 mg/kg bw
Additional information
Acute toxicity: Oral
Information for oral acute toxicity is available from one key toxicity study in male and female rats and two supporting studies in female rats only. In the key study a LD50 of 2000 and 1060 mg/kg bw is calculated for males and females, respectively. In the second study the LD50 for females there was no clear dose response and an LD50 could not be calculated. In the third study the LD50 in females was 2020.0 mg/kg bw. The doses and mortality are summarized in the table below.
Dose Mg/kg bw |
Mortality males |
Mortality females |
Dose in mg/kg bw |
Mortality females |
Dose in mg/kg bw |
Mortality females |
Key study |
|
|
Supporting study |
|
Supporting study |
|
|
|
|
|
|
590 |
1/10 |
|
|
|
630 |
1/8 |
|
|
|
|
|
790 |
5/8 |
|
|
1000 |
1/8 |
4/8 |
1000 |
7/8 |
1000 |
0/10 |
|
|
|
1260 |
8/8 |
|
|
1400 |
3/8 |
8/8 |
|
|
|
|
|
|
|
1590 |
5/8 |
|
|
|
|
|
|
|
1690 |
1/10 |
1800 |
4/8 |
7/8 |
|
|
|
|
2400 |
2/8 |
7/8 |
|
|
|
|
|
|
|
|
|
2880 |
9/10 |
3200 |
7/8 |
8/8 |
|
|
|
|
|
|
|
|
|
5000 |
9/10 |
LD50 |
2000 |
1060 |
LD50 |
790-1590 |
LD50 |
2020 |
The details regarding these studies are described below (Key study and Supporting information).
Key study
An acute oral toxicity study was performed according to a method similar to OECD TG 401, not under GLP and therefore receives Kl. 2. A reliable internal protocol was used and the study is well documented. In this study, 80 rats (40 males and 40 females) were administered Dimeth Cyclormol at dose levels of 1.0, 1.4, 1.8, 2.4, and 3.2 g/kg bw resulting in mortality rates of 1/8, 3/8, 4/8, 2/8, and 7/8 for males and 4/8, 8/8, 7/8, 7/8 and 8/8, respectively. The calculated acute oral LD50 for males was 2000 (95% Cl 1535-2606) mg/kg bw, and the calculated acute oral LD50 for females was 1060 (95% Cl 853-1318) mg/kg bw.
Clinical signs: At the lowest dose 1.0 g/kg in males and 0.63 g/kg in females, animals were prone or ataxic for the remainder of the day after dosing. Survivors recovered in the next day and appeared normal from day two and three, respectively, for the remainder of the study. At higher doses similar signs occurred and soft stools were relatively frequent. Other signs that occurred sporadically were e.g. chromodacryorrhea, clonic convulsions, and wetness of the fur around the mouth. All surviving animals gained weight in a normal pattern.
Necropsy: No signs of systemic toxicity were found in animals necropsied at termination. Common signs in animals that died were yellow fluid in the stomach (probably test article) and reddish fluid in the intestines. In two animals red lining of the intestines is observed from which one animal also showed red lining of the stomach. Furthermore in one animal black fluid in the intestines was observed and in one animal autolysis of tissue in other than standard examined tissues.
Supporting 2nd study (which is part of the report in which the key study is presented) An additional groups of 8 females were dosed 0.63, 0.79, 1.0, 1.26 and 1.59 g/kg bw and a mortality rate of 1/8, 5/8, 7/8, 8/8 and 5/8 animals was found, respectively. The LD50 in the additional females was not calculated in absence of a clear dose response. A new study in females was performed.
Supporting information, third study:
A second acute oral toxicity study was performed (IFF, 1980) according to a method similar to OECD TG 401 and under GLP. The study is a pre-guideline study and therefore rated Klimisch 2. In this study, 50 female rats were administered Dimeth Cyclormol at dose levels of 0.59, 1.0, 1.69, 2.88 and 5.0 g/kg bw resulting in mortality rates 1/10, 0/10, 1/10, 9/10 and 9/10, respectively.Clinical signsobserved were ataxia, lethargy or adoption of the prone position. Other signs were e.g. abdominal gripping, oral discharge and lacrimation.All surviving animals gained weight.
Necropsy: No lesions were found in animals necropsied at termination. Many of the animals which died had fluid filled stomachs and intestines, and red stomach linings. One animal also had red lungs and one animal had autolysis in the liver.
Conclusion: Under the conditions of this study the calculated acute oral LD50 for females was 2020 (95% Cl 700-5840) mg/kg bw.
Acute toxicity: Dermal
An acute dermal toxicity study was performed (IFF, 1980) according to a method similar to OECD TG 402 and GLP. In view of the study being a pre-guideline study it is rated Kl. 2. In this study, 8 male and 8 female rats were dosed with the undiluted test substance at 5.0 g/kg bw without occlusion; allowed to remain in contact with the skin and open to the air for 24 hours. Observation period was 14 days.
Clinical signs:The primary clinical signs which appeared following dosing were lethargy, chromodacryorrhea and chromorhinorrhea. Additionally, two animals became ataxic and had diarrhea. One of these rats recovered on day 3, and the other on day 6. Except for the one which exhibited symptoms up to day 6, all others appeared normal on day 3 and remained healthy throughout the study. Most animals gained weight in a normal manner, two females gained 10 grams or less. Necropsy: At necropsy, none of the animals had any signs indicative of systemic toxicity. No skin irritation was seen after the 14 -day observation period.
Conclusion: The LD50 was > 5000 mg/kg bw. This result does not have an impact on the classification.
Justification for classification or non-classification
Based on the available data, Dimeth Cyclormol needs to be classified for acute oral toxicity (Acute Toxicity Oral, Category 4 / H302: Harmful if swallowed) in accordance with EU CLP (1272/2008/EC and its updates).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.